The online hub for digital CME and CE courses
The ONA Forum consultants answer your questions
View articles about patient-focused care
April 01, 2013
This activity from myCME offers a review of groundbreaking molecular research and novel treatment options for patients with NSCLC.
February 15, 2013
Patients undergoing chemotherapy for hematologic cancers are at risk for this complication. The review can help you learn how to assess their risk.
December 06, 2012
A primer on what nurses need to know when scheduling items and services for patients participating in clinical trials.
October 04, 2012
Learn how patients' perceptions of health care can have a significant influence on the effectiveness of cancer care and patient education.
August 15, 2012
The CD20 antagonist is a potentially effective preventive and treatment for this common adverse effect of hematopoietic stem cell transplantation.
June 15, 2012
Signs and symptoms of venous thromboembolism in oncology patients should be heeded with prompt therapeutic and mechanical interventions.
April 13, 2012
This review describes the four major groups of leukemia, plus diagnostic tests and treatment regimens for each group.
February 15, 2012
Although the risks of erythropoietin-stimulating agents can outweigh the benefits, select patients may benefit.
December 15, 2011
VADs enable long-term IV therapy; however, the devices and their use pose a unique set of challenges for nurses.
September 21, 2011
CIPN is a debilitating adverse effect that can lead to reduced doses that hinder treatment effectiveness or early discontinuation of therapy.
July 11, 2011
Audiometric testing, awareness of the symptoms, and knowledge of which drugs are ototoxic can help protect young cancer patient's hearing.
May 16, 2011
Management and prognosis for patients with NHL depend on identifying the disease type. This review discusses the diagnoses and optimal treatments.
March 16, 2011
Identifying families at risk improves screening and counseling of patients at risk for hereditary nonpolyposis colorectal cancer.
January 14, 2011
Effective management of this nonspecific and varied symptom is based on the underlying mechanisms of action.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |
